TrialCancer science2008

Phase II study of a salvage regimen using cyclophosphamide, high-dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma.

Yasuhiro Oki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.